Vijaya Diagnostic Centre Limited (VIJAYA) - Total Liabilities

Latest as of March 2026: Rs5.50 Billion INR ≈ $59.47 Million USD

Based on the latest financial reports, Vijaya Diagnostic Centre Limited (VIJAYA) has total liabilities worth Rs5.50 Billion INR (≈ $59.47 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Vijaya Diagnostic Centre Limited to evaluate the company's liquid asset resilience ratio.

Vijaya Diagnostic Centre Limited - Total Liabilities Trend (2019–2026)

This chart illustrates how Vijaya Diagnostic Centre Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Vijaya Diagnostic Centre Limited total assets.

Vijaya Diagnostic Centre Limited Competitors by Total Liabilities

The table below lists competitors of Vijaya Diagnostic Centre Limited ranked by their total liabilities.

Company Country Total Liabilities
Carabao Group Public Company Limited
BK:CBG
Thailand ฿5.57 Billion
Guangzhou SiE Consulting Co Ltd
SHE:300687
China CN¥1.38 Billion
Sichuan Anning Iron and Titanium Co
SHE:002978
China CN¥8.35 Billion
Vivendi SA
PA:VIV
France €2.51 Billion
Century Plyboards (India) Limited
NSE:CENTURYPLY
India Rs22.99 Billion
H2O America
NASDAQ:HTO
USA $2.06 Billion
Tri Continental Closed Fund
NYSE:TY
USA $1.92 Million
Taihai Manoir Nuclear Equipment Co Ltd
SHE:002366
China CN¥2.89 Billion

Liability Composition Analysis (2019–2026)

This chart breaks down Vijaya Diagnostic Centre Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See VIJAYA equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.60 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.57 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vijaya Diagnostic Centre Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vijaya Diagnostic Centre Limited (2019–2026)

The table below shows the annual total liabilities of Vijaya Diagnostic Centre Limited from 2019 to 2026.

Year Total Liabilities Change
2026-03-31 Rs5.50 Billion
≈ $59.47 Million
+15.90%
2025-03-31 Rs4.74 Billion
≈ $51.31 Million
+46.97%
2024-03-31 Rs3.23 Billion
≈ $34.91 Million
+5.24%
2023-03-31 Rs3.07 Billion
≈ $33.18 Million
+25.77%
2022-03-31 Rs2.44 Billion
≈ $26.38 Million
+34.24%
2021-03-31 Rs1.82 Billion
≈ $19.65 Million
-12.69%
2020-03-31 Rs2.08 Billion
≈ $22.51 Million
+4.36%
2019-03-31 Rs1.99 Billion
≈ $21.57 Million
--

About Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research
Market Cap
$1.74 Billion
Rs160.56 Billion INR
Market Cap Rank
#6714 Global
#314 in India
Share Price
Rs1558.90
Change (1 day)
+3.51%
52-Week Range
Rs861.40 - Rs1558.90
All Time High
Rs1558.90
About

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more